Clinical trials: Lymphedema Arm

Breast Cancer Related Lymphoedema, Lymphoedema

LYT-100 in Patients With BCRL

• Terminated
• Age: 18 to 80 years
• Phase 2
• Results posted

This is a trial of up to 6-months duration for safety, tolerability, clinical efficacy assessments, PK and biomarkers analysis in breast carcinoma patients with secondary lymphoedema

Trial name

NCT04243837

Testing

LYT-100 BCRL

Where

8 sites in United States, Australia

Volunteers

50 people, healthy volunteers welcome

Sponsor

PureTech